Arvanitakis, Z., Wilson, R.S., Bienias, J.L., Evans, D.A., and Bennett, D.A. (2004). Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch. Neurol. 61, 661-666.
Barbieri, M., Bonafe, M., Franceschi, C., and Paolisso, G. (2003). Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am. J. Physiol. Endocrinol Metab. 285, E1064-E1071.
Blasiak, J., Arabski, M., Krupa, R., Wozniak, K., Zadrozny, M., Kasznicki et al. (2004). DNA damage and repair in type 2 diabetes mellitus. Mutation Res. 554, 297-304.
Brownlee, M. (1995). Advanced protein glycosylation in diabetes and aging. Ann. Rev. Med. 46, 223-234.
Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820.
Chaney, M.O., Baudry, J., Esh, C., Childress, J., Luehrs, D.C., Kokjohn, T.A. et al. (2003). A beta, aging, and Alzheimer's disease: A tale, models, and hypotheses. Neurological Res. 25, 581-589.
Chang, C.K. and Ulrich, C.M. (2003). Hyperinsulinaemia and hyperglycaemia: Possible risk factors of colorectal cancer among diabetic patients. Diabetologia 46, 595-607.
Coker, A.L., Sanderson, M., Zheng, W., and Fadden, M.K. (2004). Diabetes mellitus and prostate cancer risk among older men: population-based case-control study. Br. J. Cancer 90, 2171-2175.
Curb, J.D., Rodriguez, B.L., Abbott, R.D., Petrovich, H., Ross, G.W., Masaki, K.H. et al. (1999). Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology 52, 971-975.
Flood, J.F., Mooradian, A.D., and Morley, J.E. (1990). Characteristics of learning and memory in streptozotocin-induced diabetic mice. Diabetes 39, 1391-1398.
Frey, M.I., Barett-Connor, E., Sledge, P.A., Schneider, D.L., and Weisman, M.H. (1996). The effect of noninsulin dependent diabetes mellitus on the prevalence of clinical osteoarthritis. A population based study. J. Rheumatol. 23, 716-722.
Galasko, D. (2003). Insulin and Alzheimer's disease: an amyloid connection. Neurology 60, 1886-1887.
Galetic, I., Andielkovic, M., Meier, R., Brodbeck, D., Park, J., and Hemmings, B.A. (1999). Mechanism of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinase—Significance for diabetes and cancer. Pharmacol. & Therapeut. 82, 409-425.
Gavard, J.A., Lustman, P.J., and Clouse R.E. (1993). Prevalence of depression in adults with diabetes. Diabetes Care 16, 1167-1178.
Giannakou, M.E., Goss, M., Junger, M.A., Hafen, E., Leevers, S.J., and Partridge, L. (2004). Long-lived Drosophila with over expressed dFOXO in adult fat body. Science 305, 361.
Giovannucci, E. (2001). Insulin, insulin-like growth factors and colon cancer: A review of the evidence. J. Nutrition 131 (Suppl 11), 3109S-3120S.
Guastamacchia, E., Resta, F., Triggiani, V., Liso, A., Licchelli, B., Ghiyasaldin, S. et al. (2004). Evidence for a putative relationship between type 2 diabetes and neoplasia with particular reference to breast cancer: Role of hormones, growth factors and specific receptors. Current Drug Targets—Immune Endocrine & Metabolic Disorders 4, 59-66.
Harris, M.I., Flegal, K.M., Cowie, C.C., Eberhardt, M.S., Goldstein, D.E., Little, R.R. et al. (1998). Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21, 518-524.
Hasanain, B. and Mooradian, A.D. (2002). Antioxidants and their influence in diabetes. Current Diabetes Reports 2, 448-456.
Hasnain, B.I. and Mooradian, A.D. (2004). Clinical implications of recent trials of antioxidant therapy: What should we be telling our patients? Cleveland Clin. J. Med. 71, 327-334.
Henderson, S.T. and Johnson, T.E. (2001). daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr. Biol. 11, 1975-1980.
Horani, M.H., Haas, M.J., and Mooradian, A.D. (2004). Rapid adaptive down regulation of oxidative burst induced by high dextrose in human umbilical vein endothelial cells. Diabetes Research and Clinical Practice 66, 7-12.
Hu, F.B., Meigs, J.B., Li, T.Y., Rifai, N., and Manson, J.E. (2004). Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53, 693-700.
Idris, I., Gray, S., and Donnelly, R. (2001). Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 44, 659-673.
Inzerillo, A.M. and Epstein, S. (2004). Osteoporosis and diabetes mellitus. Rev. Endocrine & Metabolic Disorders 5, 261-268.
Janson, J., Laedtke, T., Parisi, J.E., O'Brien, P., Petersen, R.C., and Butler, P.C. (2004). Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53, 474-481.
Kalmijn, S., Feskens, E.J., Launer, L.J., Stijnen, T., and Kromhout, D. (1995). Glucose tolerance, hyperinsulinemia and cognitive function in a general population of elderly men. Diabetologia 38, 1096-1102.
Kawakami, T., Kawakami, Y., and Kitaura, J. (2002). Protein kinase C beta (PKC beta): Normal functions and diseases. J Biochem (Tokyo) 132, 677-682.
Kenyon, C., Chang, J., Gensch, E., Rudner, A., and Tabtiang, R. (1993). A C. elegans mutant that lives twice as long as wild type. Nature 366, 461-464.
Khaw, K.T., Wareham, N., Luben, R., Bingham, S., Oakes, S., Welch, A. et al. (2001). Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 322, 15-18.
Khaw, K.T., Wareham, N., Bingham, S., Luben, R., Welch, A., and Day, N. (2004). Preliminary communication: Glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiology, Biomarkers & Prevention 13, 915-919.
Lustman, P.J., Griffith, L.S., Clouse, R.E., and Cryer, P.E. (1986). Psychiatric illness in diabetes mellitus: relation to symptoms and glucose control. J. Nerv. Ment. Dis. 174, 736-746.
Michels, K.B., Solomon, C.G., Hu, F.B., Rosner, B.A., Hankinson, S.E., Colditz, G.A. et al. (2003). Nurses' Health Study. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 26, 1752-1758.
Mooradian, A.D. (1988a). Nutritional modulation of life span and gene expression. In J.E. Morley, Moderator, Nutrition in the elderly, pp. 891-892. Ann. Int. Med. 109, 890-904.
Mooradian, A.D. (1988b). Diabetic complications of the central nervous system. Endocrine Reviews 9, 346-356.
Mooradian, A.D. (1988c). Tissue specificity of premature aging in diabetes mellitus: The role of cellular replicative capacity. J. Am. Geriatr. Soc. 36, 831-839.
Mooradian, A.D. (1990). Biomarkers of aging: Do we know what to look for? J. Gerontol. Biol. Sci. 45, B183-B186.
Mooradian, A.D. (1994). Biology of Aging. In G. Felsenthal, S.J. Garrison, F.U. Steinberg, Eds., Rehabilitation of the Aging and Elderly Patient. Baltimore, MD: Williams and Wilkins, pp. 3-10.
Mooradian, A.D. (1995a). Theories of Aging. In J.E. Morley, Z. Glick, and L.Z. Rubenstein, Eds., Geriatric Nutrition: A Comprehensive Review. New York: Raven Press, pp. 5-13.
Mooradian, A.D. (1995b). The antioxidative potential of cerebral microvessels in experimental diabetes mellitus. Brain Res. 671, 164-169.
Mooradian, A.D. (1996). Glycosylation enhances malondialde-hyde binding to proteins. Free Radical Biol. Med. 21, 699-701.
Mooradian, A.D. (1997a). Central nervous system complications of diabetes mellitus. A perspective from the blood-brain barrier. Brain Res. Rev. 23, 210-218.
Mooradian, A.D. (1997b). Pathophysiology of central nervous system disorders in diabetes. Clin. Neurosci. 4, 322-326.
Mooradian, A.D. (2003). Cardiovascular disease in type 2 diabetes mellitus: Current management guidelines. Arch. Intern. Med. 163, 33-40.
Mooradian, A.D. and Chehade, J. (2000). Implications of the UK Prospective Diabetes Study: Questions answered and issues remaining. Drugs and Ageing 16, 159-164.
Mooradian, A.D., Chung, H.C., and Shah, G.N. (1997). GLUT-1 expression in the cerebra of patients with Alzheimer's disease. Neurobiol Aging 18, 469-474.
Mooradian, A.D. and Mariash, C.N. (1987). Effects of insulin and glucose on cultured rat hepatocyte gene expression. Diabetes 36, 938-943.
Mooradian, A.D., Perryman, K., Fitten, J., Kavonian, G., and Morley, J.E. (1988). Cortical function in elderly non-insulin dependent diabetic patients: Behavioral and electrophysiolo-gical studies. Arch. Int. Med. 148, 2369-2372.
Mooradian, A.D. and Thurman, J.E. (1999a). Drug therapy of postprandial hyperglycemia. Drugs 57, 19-29.
Mooradian, A.D. and Thurman, J. (1999b). Glucotoxicity: Potential mechanisms. Clinics in Geriatric Medicine 15, 255-263.
Mooradian, A.D. and Uko-eninn, A. (1995). Age-related changes in the antioxidative potential of cerebral microvessels. Brain Res. 671, 159-163.
Newton, A.C. (1995). Protein kinase C: Structure, function, and regulation. J. Biol. Chem. 270, 28495-28498.
Pardee, K., Reinking, J., and Krause, H. (2004). Nuclear hormone receptors, metabolism, and aging. Science 306, 1446-1447.
Rasgon, N. and Jarvik, L. (2004). Insulin resistance, affective disorders, and Alzheimer's disease: Review and hypothesis. J Gerontol. Series A-Biol. Sci. & Med. Sci. 59, 178-183.
Rohlfing, C.L., Wiedmeyer, H.M., Little, R.R., England, J.D., Tennill, A., and Goldstein, D.E. (2002). Defining the relationship between plasma glucose and HbA(1c): Analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 25, 275-278.
Ryan, C.M. (1988). Neurobehavioral complication of type 1 diabetes. Examination of possible risk factors. Diabetes Care 11, 86-93.
Sasaki, N., Toki, S., Chowei, H., Saito, T., Nakano, N., Takeuchi, M. et al. (2001). Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Research 888, 256-262.
Schwartz, A.V. (2003). Diabetes mellitus: does it affect bone? Calc. Tissue Int. 73, 515-519.
Selvin, E., Marinopoulos, S., Berkenblit, G., Rami, T., Brancati, F.L., Powe, N.R. et al. (2004). Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann. Intern. Med. 141, 421-431.
Shah, G.N. and Mooradian, A.D. (1997). Age-related changes in the blood brain barrier. Exp. Gerontol. 32, 501-519.
Sinagra, D., Amato, C., Scarpilta, A.M., Brigamdi, M., Amato, M., Saura, G. et al. (2002). Metabolic syndrome and breast cancer risk. Eur. Rev. Med. & Pharmacol. Sci. 6, 55-59.
Songer, T. (1995). Disability in diabetes. In M. Harris, C. Cowie, and M. Stern, Eds., Diabetes in America, 2e. Bethesda, MD: National Institute of Health; pp. 259-282.
Spranger, J., Kroke, A., Mohlig, M., Hoffmann, K., Bergmann, M.M., Ristow, M. et al. (2003). Inflammatory cytokines and the risk to develop type 2 diabetes: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52(3), 812-817.
Strachan, M.W., Deary, I.J., Ewing, F.M., and Frier, B.M. (1997). Is type 2 diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20, 438-445.
Stratton, I.M., Adler, A.I., Neil, H.A., Matthews, D.R., Manley, S.E., Cull, C.A. et al. (2000). Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321, 405-412.
UK Prospective Diabetes Study Group. (1998a). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837-853.
UK Prospective Diabetes Study. (1998b). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352, 854-865.
Watanabe, S., Takeuchi, Y., Fukumoto, S., Fujita, H., Nakano, T., and Fujita, T. (2003). Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients. J. Bone & Min. Metab. 21, 166-171.
Wehmeier, K.R. and Mooradian, A.D. (1994). Autooxidative and antioxidative potential of simple carbohydrate. Free Radical in Biol. Med. 17, 83-86.
Wu, L.L., Chiou, C.C., Chang, P.Y., and Wu, J.T. (2004). Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clinica Chimica Acta 339, 1-9.
Yang, Y.X., Hennessy, S., and Lewis, J.D. (2004). Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 127, 1044-1050.
Zendehdel, K., Nyren, O., Ostenson, C.G., Adami, H.O., Ekbom, A., and Ye, W. (2003). Cancer incidence in patients with type 1 diabetes mellitus: A population-based cohort study in Sweden. J. Nat. Cancer Inst. 95, 1797-1800.
Zhu, K., Lee, I.M., Sesso, H.D., Buring, J.E., Levine, R.S., and Gaziano, J.M. (2004). History of diabetes mellitus and risk of prostate cancer in physicians. Am. J. Epidemiol. 159, 978-982.
This page intentionally left blank
Was this article helpful?